The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
INI1-Deficient Tumors: Diagnostic Features and Molecular Genetics
Abstract
Significant progress has been made in understanding the molecular genetic alterations involved in sarcomagenesis. Cytogenetic and molecular studies have identified nonrandom genetic abnormalities, including tumor suppressor gene inactivation. Mutations, deletions, and other somatic alterations in the tumor suppressor gene INI1 (hSNF5; SMARCB1), which encodes a subunit of the SWI/SNF chromatin remodeling complex, were first described in the malignant rhabdoid tumor of infancy. Since then, INI1 has also been implicated in the pathogenesis of additional tumor types including renal medullary carcinomas and epithelioid sarcomas and a subset of epithelioid malignant peripheral nerve sheath tumors, myoepithelial carcinomas, and extraskeletal myxoid chondrosarcomas. As varied as this group appears, they all show loss of INI1 protein expression, a propensity for rhabdoid cytomorphology, and sometimes other overlapping immunohistochemical and histologic findings. We will review the clinicopathologic features of these tumor types and emphasize the clinical utility of INI1 immunohistochemistry in differential diagnosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer
Versteege, I., Sévenet, N., Lange, J., Rousseau-Merck, M.-F., Ambros, P., Handgretinger, R., Aurias, A., & Delattre, O. (1998) · Nature · doi:10.1038/28212 · Cited by 1,556
The Third Intergroup Rhabdomyosarcoma Study.
Crist, W., Gehan, E. A., Ragab, A. H., Dickman, P. S., Donaldson, S. S., Fryer, C., Hammond, D., Hays, D. M., Herrmann, J., & Heyn, R. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.3.610 · Cited by 999
Germ-line and acquired mutations of INI1 in atypical teratoid and rhabdoid tumors.
Biegel, J. A., Zhou, J. Y., RORKE, L. B., Stenstrom, C., Wainwright, L. M., & Fogelgren, B. (1999) · PubMed · Cited by 836
RORKE, L. B., Packer, R. J., & Biegel, J. A. (1996) · Journal of neurosurgery · doi:10.3171/jns.1996.85.1.0056 · Cited by 799
The SWI/SNF complex — chromatin and cancer
Roberts, C. W. M., & Orkin, S. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1273 · Cited by 603
Renal Medullary Carcinoma The Seventh Sickle Cell Nephropathy
Davis, C. J., Mostofi, F. K., & Sesterhenn, I. A. (1995) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199501000-00001 · Cited by 599
Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma.
Davis, R. J., D’Cruz, C. M., Lovell, M. A., Biegel, J. A., & Barr, F. G. (1994) · PubMed · Cited by 585
Ladanyi, M., Antonescu, C. R., Leung, D. H. Y., Woodruff, J. M., Kawai, A., Healey, J. H., Brennan, M. F., Bridge, J. A., Neff, J. R., Barr, F. G., et al. (2002) · PubMed · Cited by 536
Haploinsufficiency of Snf5 (integrase interactor 1) predisposes to malignant rhabdoid tumors in mice
Roberts, C. W. M., Galusha, S. A., McMenamin, M. E., Fletcher, C. D. M., & Orkin, S. H. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250492697 · Cited by 433
Burger, P. C., Yu, I.-T., Tihan, T., Friedman, H. S., Strother, D. R., Kepner, J. L., Duffner, P. K., Kun, L. E., & Perlman, E. J. (1998) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199809000-00007 · Cited by 432
Weeks, D. A., Beckwith, J. B., Mierau, G. W., & Luckey, D. W. (1989) · PubMed · Cited by 400
Germline Mutation of INI1/SMARCB1 in Familial Schwannomatosis
Hulsebos, T. J. M., Plomp, A. S., Wolterman, R. A., Robanus-Maandag, E. C., Baas, F., & Wesseling, P. (2007) · The American Journal of Human Genetics · doi:10.1086/513207 · Cited by 398
Spectrum of SMARCB1/INI1 mutations in familial and sporadic rhabdoid tumors
Eaton, K. W., Tooke, L. S., Wainwright, L. M., Judkins, A. R., & Biegel, J. A. (2011) · Pediatric Blood & Cancer · doi:10.1002/pbc.22831 · Cited by 384
Terry, J., Saito, T., Subramanian, S., Ruttan, C., Antonescu, C. R., Goldblum, J. R., Downs-Kelly, E., Corless, C. L., Rubin, B. P., van de Rijn, M., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213330.71745.39 · Cited by 351
SMARCB1/INI1 Tumor Suppressor Gene Is Frequently Inactivated in Epithelioid Sarcomas
Modena, P., Lualdi, E., Facchinetti, F., Galli, L., Teixeira, M. R., Pilotti, S., & Sozzi, G. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3050 · Cited by 335
Roberts, C. W. M., Leroux, M. M., Fleming, M. D., & Orkin, S. H. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00185-x · Cited by 333
A specific chromosomal abnormality in rhabdomyosarcoma
Douglass, E. C., Valentine, M., Etcubanas, E., Parham, D., Webber, B. L., Houghton, P. J., & Green, A. A. (1987) · Cytogenetic and Genome Research · doi:10.1159/000132446 · Cited by 322
Disruption of Ini1 Leads to Peri-Implantation Lethality and Tumorigenesis in Mice
Guidi, C. J., Sands, A. T., Zambrowicz, B. P., Turner, T. K., Demers, D. A., Webster, W., Smith, T. W., Imbalzano, A. N., & Jones, S. N. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.10.3598-3603.2001 · Cited by 295
Infant Cancer in the U.S.: Histology-Specific Incidence and Trends, 1973 to 1992
Gurney, J. G., Ross, J. A., Wall, D. A., Bleyer, W. A., Severson, R. K., & Robison, L. L. (1997) · Journal of Pediatric Hematology/Oncology · doi:10.1097/00043426-199709000-00004 · Cited by 276
Newton, W. A., Soule, E. H., Hamoudi, A. B., Reiman, H. M., Shimada, H., Beltangady, M., & Maurer, H. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.1.67 · Cited by 267
Cytokeratin expression in epithelioid vascular neoplasms
Gray, M. H., Rosenberg, A. E., Dickersin, G. R., & Bhan, A. K. (1990) · Human Pathology · doi:10.1016/0046-8177(90)90131-n · Cited by 253
Fusions of the SYT and SSX genes in synovial sarcoma
Ladanyi, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204601 · Cited by 242
Expression of PAX8 in normal and neoplastic renal tissues: an immunohistochemical study
Tong, G.-X., Yu, W. M., Beaubier, N. T., Weeden, E. M., Hamele-Bena, D., Mansukhani, M. M., & O'Toole, K. M. (2009) · Modern Pathology · doi:10.1038/modpathol.2009.88 · Cited by 238
Swartz, M. A., Karth, J., Schneider, D. T., Rodriguez, R., Beckwith, J. B., & Perlman, E. J. (2002) · Urology · doi:10.1016/s0090-4295(02)02154-4 · Cited by 228
Consistent chromosomal translocation in alveolar rhabdomyosarcoma
Turc-Carel, C., Lizard-Nacol, S., Justrabo, E., Favrot, M., Philip, T., & Tabone, E. (1986) · Cancer Genetics and Cytogenetics · doi:10.1016/0165-4608(86)90069-5 · Cited by 228
Frequent hSNF5/INI1 Germline Mutations in Patients with Rhabdoid Tumor
Bourdeaut, F., Lequin, D., Brugières, L., Reynaud, S., Dufour, C., Doz, F., André, N., Stephan, J.-L., Pérel, Y., Oberlin, O., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1795 · Cited by 224
Trobaugh‐Lotrario, A. D., Tomlinson, G. E., Finegold, M. J., Gore, L., & Feusner, J. H. (2009) · Pediatric Blood & Cancer · doi:10.1002/pbc.21834 · Cited by 171
Prospective Evaluation of TLE1 as a Diagnostic Immunohistochemical Marker in Synovial Sarcoma
Jagdis, A., Rubin, B. P., Tubbs, R. R., Pacheco, M., & Nielsen, T. O. (2009) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181b7ed36 · Cited by 167
Oliveira, A. M., Sebo, T. J., McGrory, J. E., Gaffey, T. A., Rock, M. G., & Nascimento, A. G. (2000) · Modern Pathology · doi:10.1038/modpathol.3880161 · Cited by 163
Smith, T., Machen, S. K., Fisher, C., et al. (1999) · American Journal of Clinical Pathology · doi:10.1093/ajcp/112.5.641 · Cited by 139
Brandal, P., Panagopoulos, I., Bjerkehagen, B., Gorunova, L., Skjeldal, S., Micci, F., & Heim, S. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20559 · Cited by 132
Reduced expression of SMARCB1/INI1 protein in synovial sarcoma
Kohashi, K., Oda, Y., Yamamoto, H., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.71 · Cited by 125
Cin, P. D., Sciot, R., Panagopoulos, I., Åman, P., Samson, I., Mandahl, N., Mitelman, F., BERGHE, H. V. D., & Fletcher, C. D. �. (1997) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199708)182:4<437::aid-path882>3.0.co;2-x · Cited by 117
Sjögren, H., Meis‐Kindblom, J. M., Örndal, C., Bergh, P., Ptaszyński, K., Åman, P., Kindblom, L., & Stenman, G. (2003) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63875-8 · Cited by 114
TFG is a novel fusion partner of NOR1 in extraskeletal myxoid chondrosarcoma
Hisaoka, M., Ishida, T., Imamura, T., & Hashimoto, H. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20044 · Cited by 106
Swensen, J. J., Keyser, J., Coffin, C. M., Biegel, J. A., Viskochil, D. H., & Williams, M. S. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2008.060152 · Cited by 105
Renal medullary carcinoma: report of seven cases from Brazil
Watanabe, I. C., Billis, A., Guimarães, M. S., Alvarenga, M., de Matos, A. C., Cardinalli, I. A., Filippi, R. Z., de Castro, M. G., & Suzigan, S. (2007) · Modern Pathology · doi:10.1038/modpathol.3800934 · Cited by 104
SMARCB1/INI1 germline mutations contribute to 10% of sporadic schwannomatosis
Rousseau, G., Noguchi, T., Bourdon, V., Sobol, H., & Olschwang, S. (2011) · BMC Neurology · doi:10.1186/1471-2377-11-9 · Cited by 93
Epithelioid Sarcoma: New Insights Based on an Extended Immunohistochemical Analysis
Laskin, W. B., & Miettinen, M. (2003) · Archives of Pathology & Laboratory Medicine · doi:10.5858/2003-127-1161-esnibo · Cited by 92
Biegel, J. A., Conard, K. A., & Brooks, J. J. S. (1993) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870070210 · Cited by 92
DeCristofaro, M. F., Betz, B. L., Wang, W., & Weissman, B. E. (1999) · Oncogene · doi:10.1038/sj.onc.1203168 · Cited by 87
Chromosomal Translocation t(1;13)(p36;q14) in a Case of Rhabdomyosarcoma
Biegel, J. A., Meek, R. S., Parmiter, A. H., Conard, K. A., & Emanuel, B. S. (1991) · Genes Chromosomes and Cancer · doi:10.1002/gcc.2870030612 · Cited by 83
Katz, R. L., Quezado, M., Senderowicz, A. M., Villalba, L., Laskin, W. B., & Tsokos, M. (1997) · Human Pathology · doi:10.1016/s0046-8177(97)90042-3 · Cited by 71
Watanabe, H., Mizutani, T., Haraguchi, T., Yamamichi, N., Minoguchi, S., Yamamichi-Nishina, M., Mori, N., Kameda, T., Sugiyama, T., & Iba, H. (2005) · Oncogene · doi:10.1038/sj.onc.1209068 · Cited by 71
AN IMMUNOCYTOCHEMICAL ASSESSMENT OF 19 CASES OF CUTANEOUS ANGIOSARCOMA
Orchard, G. E., Zelger, B. W. H., Jones, E. W., & Jones, R. R. (1996) · Histopathology · doi:10.1046/j.1365-2559.1996.d01-411.x · Cited by 60
Orrock, J. M., Abbott, J. J., Gibson, L. E., & Folpe, A. L. (2009) · American Journal of Dermatopathology · doi:10.1097/dad.0b013e31818a5c4f · Cited by 44
(1993) · doi:10.1002/1097-0142(19930301)71:5<1904::aid-cncr2820710530>3.0.co;2-x
Cited by
Epigenetic Therapies for Cancer
Bates, S. E. (2020) · New England Journal of Medicine · doi:10.1056/nejmra1805035 · Cited by 493
Hoy, S. M. (2020) · Drugs · doi:10.1007/s40265-020-01288-x · Cited by 338
Rekhtman, N., Montecalvo, J., Chang, J. C., Alex, D., Ptashkin, R. N., Ai, N., Sauter, J. L., Kezlarian, B., Jungbluth, A., Desmeules, P., et al. (2020) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2019.10.023 · Cited by 326
SWI/SNF Chromatin Remodeling and Human Malignancies
Masliah-Planchon, J., Bièche, I., Guinebretière, J.-M., Bourdeaut, F., & Delattre, O. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040445 · Cited by 316
Checkpoint immunotherapy in pediatrics: here, gone, and back again
Long, A. H., Morgenstern, D. A., Leruste, A., Bourdeaut, F., & Davis, K. L. (2022) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_349799 · Cited by 53
Metadata
- Authors
- Hollmann, T. J., & Hornick, J. L.
- Venue
- American Journal of Surgical Pathology
- Published
- 2011-10
- Volume
- 35
- Issue
- 10
- Pages
- e47-e63
- ISSN
- 0147-5185 (ISSN-L)
- OpenAlex
- W2028257398
- Cited by
- 427
- References
- 47
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.